Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acid, adequacy, alopecia, ASCENT, atezolizumab, banking, baseline, bevacizumab, biopsy, broader, caution, Chapel, commodity, conditionally, confidence, copy, crypt, curative, DEI, Delinquent, diarrhea, died, discretionary, DMC, doublet, doubt, familiarity, folinic, foundational, greatly, hair, HHS, Hill, hybrid, hydrochloride, identification, Incyclix, inflationary, intestinal, IRA, irinotecan, Joe, lurbinectedin, midyear, NMPA, Norman, outpace, oxaliplatin, Pembrolizumab, poster, proper, protectionism, Raymond, recession, RECIST, refractory, residual, round, School, Science, simultaneously, sixtieth, spent, streamline, sudden, taxane, tied, top, topline, triplet, Ukraine, Umstead, unbilled, unrealized, verification, week, weekly, weigh, workforce
Removed:
activate, afford, arrange, bankruptcy, blocking, cancelable, converted, creditable, Deese, degrader, detail, detection, deteriorate, display, disposition, draft, encumbrance, endorsement, Eurasia, execution, expenditure, explore, insolvency, Integrated, investor, logo, month, myelopreservation, nonqualified, organizing, pertain, prevention, receptor, reliability, revert, Rudnick, Seth, speculative, sponsorship, sublicensing, Suite, telephone, thirty, viability, Willie
Filing tables
Filing exhibits
Related press release
Associated GTHX transcripts
GTHX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-265832, 333-254705, 333-236229, 333-232106, 333-226701, and 333-218468) and Form S-3 (Nos. 333-257640 and 333-225678) of G1 Therapeutics, Inc. of our report dated March 1, 2023 relating to the financial statements, which appear in this Form 10-K.
Raleigh, North Carolina
March 1, 2023